AD04 – modifying Alzheimer’s Disease by modulation of neuroinflammation
Carmela R Abraham, Achim Schneeberger, Agustin F Santana III, Thomas Hoffmann, Anita Fischer, Sylvie Trembleau · 2025
Read AD04 – modifying Alzheimer’s Disease by modulation of neuroinflammation by Carmela R Abraham, Achim Schneeberger, Agustin F Santana III, Thomas Hoffmann, Anita Fischer, Sylvie Trembleau (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713042.txt.
Description
A shot additive used in vaccines for decades may slow Alzheimer's disease when given at one set dose. Carmela Abraham and five co-authors report in 2025 on that agent, called AD04, first seen as a mere control arm in a trial. In folk with mild disease it slowed the brain's memory hub from shrinking and held back mind slide. Its score on a blend of three standard scales matched or beat most drugs on the shelf.
To find how a skin shot reaches the brain, the team dosed old mice and ran a fear test. Treated old mice froze more aptly, a sign of sound recall. Their memory hubs showed shifts in fat handling and in guard cells, which turned toward eating dead cell waste. The team read the guard-cell turn as the likely path of the gain.
Catalog record
| CREATOR | Carmela R Abraham, Achim Schneeberger, Agustin F Santana III, Thomas Hoffmann, Anita Fischer, Sylvie Trembleau |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |